Overview

Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
To compare colon cleansing quality induced by the 2 different modes of MOVIPREP® intake in 5 colon segments prior to colonoscopy.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Collaborator:
Norgine BV